课题基金 / 基金详情

DENDRITIC CELLS ACTIVATED BY GMCSF & IL4 AS A TUMOR VACCINE IN ADVANCED CANCER

DENDRITIC CELLS ACTIVATED BY GMCSF & IL4 AS A TUMOR VACCINE IN ADVANCED CANCER
GMCSF 激活的树突状细胞
批准号:
6113535
负责人:
ALFRED E CHANG
金额:
$0.02万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

ALFRED E CHANG的其他基金

相似基金

相关文献

中文摘要
翻译
这些临床前研究为临床评估人类树突状细胞与肿瘤裂解液脉冲治疗晚期癌症患者提供了依据。
英文摘要
These preclinical studies serve as rationale for a clinical evaluation of human dendritic cells pulsed with tumor lysate for patients with advanced cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IMMUNOLOGICAL MONITORING
RESEARCH TRAINING IN TRANSLATIONAL TUMOR IMMUNOLOGY
IMMUNE RESPONSES INDUCED BY GENE TRANSFER
IMMUNE RESPONSES INDUCED BY GENE TRANSFER
海外基金